Global market for drugs to treat immune diseases to reach $82.2 billion by 2015

October 10, 2012

In 2010, the global drug market for the treatment of immune disease was estimated to be approximately $72.2 billion. The market size is forecast to grow at a compound annual growth rate (CAGR) of 2.6% to reach $82.2 billion by 2015.

Learn about the market for small–molecules and biologic therapies for diseases caused by disorders of the immune system. Get information on of various technology types used to contain undesirable immune responses and drugs in each category, key challenges, players in the market along with company profiles and patent analysis…

Use this report to:

  • Understand how the most prevalent technologies in the immune system disorders therapeutic market have changed over the past decade with the advent of biologics and drugs with novel methods of delivery
  • Identify the various regulatory and market trends that will impact major immune disease segments during the forecast period and how they will influence your future business strategies
  • Examine the current market for the treatment of immune disease and develop effective marketing strategies based on the projected effects of new technologies upon this market
  • Maintain a competitive standing with an in–depth analysis of leading companies and their successful strategies.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

RSS Feeds – Biotechnology

SUMMARY FIGURE
GLOBAL MARKET FOR DRUGS TO TREAT IMMUNE DISEASES, 2009-2015
($ MILLIONS)


Source: BCC Research

Global markets for biomakers to grow to $33.3 billion by 2015

October 9, 2012

In 2010, the total market for biomarkers is expected to be nearly $13.5 billion and is expected to grow to nearly $33.3 billion by the end of 2015 at a 5-year compound annual growth rate (CAGR) of 19.8%.

Learn about the various types of biomarkers and get an analysis of global market trends with projections through 2015. This report provides a range of information including detailed product analyses within disease sub segments, technological issues, regulatory issues and company profiles…

Use this report to:

  • Quantify and qualify the market for products and services in the biomarkers segment
  • Evaluate the introduction of combination therapies in the biomarkers arena, an important market driver expected to contribute substantially to market growth through the 5-year forecast period
  • Allocate resources and make effective decisions regarding emerging players, technologies, and markets in relation to specific disease segments
  • Examine the industry structure with a special focus on how new products and technologies anticipated to be released during the forecast period will influence the current standard of care and change the competitive environment.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

RSS Feeds – Biotechnology

SUMMARY FIGURE
GLOBAL BIOMARKERS FORECAST BY AREA, THROUGH 2015
($ MILLIONS)
Source: BCC Research

Global market for drugs to treat immune diseases to reach $82.2 billion by 2015

October 4, 2012

In 2010, the global drug market for the treatment of immune disease was estimated to be approximately $72.2 billion. The market size is forecast to grow at a compound annual growth rate (CAGR) of 2.6% to reach $82.2 billion by 2015.

Learn about the market for small–molecules and biologic therapies for diseases caused by disorders of the immune system. Get information on of various technology types used to contain undesirable immune responses and drugs in each category, key challenges, players in the market along with company profiles and patent analysis…

Use this report to:

  • Understand how the most prevalent technologies in the immune system disorders therapeutic market have changed over the past decade with the advent of biologics and drugs with novel methods of delivery
  • Identify the various regulatory and market trends that will impact major immune disease segments during the forecast period and how they will influence your future business strategies
  • Examine the current market for the treatment of immune disease and develop effective marketing strategies based on the projected effects of new technologies upon this market
  • Maintain a competitive standing with an in–depth analysis of leading companies and their successful strategies.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

RSS Feeds – Biotechnology

SUMMARY FIGURE
GLOBAL MARKET FOR DRUGS TO TREAT IMMUNE DISEASES, 2009-2015
($ MILLIONS)
Source: BCC Research

Global markets for RNAi drug & technologies to reach $24.1 billion by 2015

October 3, 2012

The global RNA interference (RNAi)  drug delivery market was worth $7 billion in 2010 and is expected to grow to nearly $24.1 billion by 2015 at a 5-year compound annual growth rate (CAGR) of 27.9%.

Learn about the latest trends in RNAi therapeutics, with focus on the main areas of clinical need, general/proprietary technologies and company pipelines, and the activities and strategies of RNAi-based developers. This report also provides forecasts for market growth to 2015 across major RNAi market segments…

Use this report to:

  • Learn about emerging RNAi molecules and delivery technologies as well as new molecular targets and pipeline drugs
  • Assess important trends in technology development for RNAi in major therapeutic areas and licensing opportunities for novel delivery platforms
  • Evaluate the commercial potential of emerging therapeutics and delivery technologies based on crucial statistics and analysis of the market structure, market size, and key drug segments
  • Incorporate analysis of competitors and collaborators in developing RNAi technologies, the market shares of key players and drugs, and the latest RNAi-related patenting trends into your business strategy.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

RSS Feeds – Biotechnology

SUMMARY FIGURE
GLOBAL MARKET FOR RNAI DRUG DELIVERY TECHNOLOGIES, 2009-2015
($ MILLIONS)
Source: BCC Research

Overall biologics market to grow $239 billion by 2015

September 25, 2012

The overall biologics market was $135 billion in 2009, and is expected to grow to $149 billion in 2010, a 9.4% growth rate. The total market is expected to grow to $239 billion by 2015, a compound annual growth rate (CAGR) of 9.9% since 2010.

Learn about the market for biologics, or biopharmaceuticals, on a global basis. This report includes chapters on industry structure and competitive analysis, markets by product type and disease, biologics manufacturing, pipeline analysis and relevant company profiles…

Use this report to:

  • Understand the factors that will advance biologics, or large molecule drug.
  • Anticipate and prepare for programs that are expected to dominate the biopharmaceutical marketplace and change market dynamics in the coming years.
  • Develop strategies to access emerging markets, specific disease segments, and geographies in order to allocate resources and make effective decisions.
  • Learn about the strategies of companies poised to introduce novel products during the forecast period, how these introductions will change the competitive environment, and how new products and technologies are influencing the current standard of care.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

RSS Feeds – Biotechnology

SUMMARY FIGURE
GLOBAL BIOLOGICS MARKET FORECAST BY TYPE OF PRODUCT, 2009-2015
($ BILLIONS)

Source: BCC Research

Global market for ultrasonic equipment to reach $27.7 billion in 2016

September 25, 2012

The global market for ultrasonic equipment in 2010 was $16.4 billion. This is expected to reach nearly $17.6 billion in 2011 and then further increase to $27.7 billion in 2016, at a compound annual growth rate (CAGR) of 9.6% for the 5-year period.Learn about the global and regional markets for various types of ultrasonic technologies and products with reasons given for variations in the growth of the industry in certain regions…

Use this report to:

  • Understand the essentials of the ultrasonic technologies and products market, including definitions, processes, dynamics, and trends
  • Identify viable technology drivers through a comprehensive look at various platform technologies for new and existing ultrasound products and application markets
  • Evaluate ultrasonics market opportunities and develop targeted promotion plans by identifying high-growth applications in expanding markets
  • Stay on top of competitor initiatives to meet the market demand for various types of ultrasonic products.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

RSS Feeds – Manufacturing

GLOBAL ULTRASONIC MARKET, 2009-2016
($ MILLIONS)

Global markets for RNAi drug & technologies to reach $24.1 billion by 2015

September 18, 2012

The global RNA interference (RNAi)  drug delivery market was worth $7 billion in 2010 and is expected to grow to nearly $24.1 billion by 2015 at a 5-year compound annual growth rate (CAGR) of 27.9%.

Learn about the latest trends in RNAi therapeutics, with focus on the main areas of clinical need, general/proprietary technologies and company pipelines, and the activities and strategies of RNAi-based developers. This report also provides forecasts for market growth to 2015 across major RNAi market segments…

Use this report to:

  • Learn about emerging RNAi molecules and delivery technologies as well as new molecular targets and pipeline drugs
  • Assess important trends in technology development for RNAi in major therapeutic areas and licensing opportunities for novel delivery platforms
  • Evaluate the commercial potential of emerging therapeutics and delivery technologies based on crucial statistics and analysis of the market structure, market size, and key drug segments
  • Incorporate analysis of competitors and collaborators in developing RNAi technologies, the market shares of key players and drugs, and the latest RNAi-related patenting trends into your business strategy.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

RSS Feeds – Biotechnology

SUMMARY FIGURE
GLOBAL MARKET FOR RNAI DRUG DELIVERY TECHNOLOGIES, 2009-2015
($ MILLIONS)
Source: BCC Research